US2123264093 - Common Stock
CONTRAFECT CORP
NASDAQ:CFRX (11/8/2023, 7:26:06 PM)
After market: 0.171 -0.06 (-26.23%)0.2318
+0.01 (+2.84%)
ContraFect Corp. is a clinical stage biotechnology company, which engages in the discovery and development of direct lytic agents (DLAs), including lysins and amurin peptides, as new medical modalities for the treatment of life-threatening, antibiotic-resistant infections. The company is headquartered in Yonkers, New York and currently employs 23 full-time employees. The company went IPO on 2014-07-29. The firm is focused on the discovery and development of direct lytic agents (DLAs), including lysins and amurin peptides, as new medical modalities for the treatment of life-threatening, antibiotic-resistant infections. Its lead DLA product candidate, exebacase (CF-301), is used for the treatment of methicillin-resistant S. aureus (MRSA) bloodstream infections (bacteremia), including right-sided endocarditis, when used in addition to standard-of-care (SOC) anti-staphylococcal antibiotics in adult patients. Its CF-301 is being studied in an ongoing Phase Ib/II study in patients with chronic prosthetic joint infections (PJIs) of the knee due to S. aureus or coagulase-negative Staphylococci. Its other product candidate, CF-370, is designed to target a range of gram-negative bacteria, including P. aeruginosa, K. pneumoniae, and A. baumanni, and has demonstrated potent in vivo activity against these pathogens.
CONTRAFECT CORP
28 Wells Avenue, 3rd Floor
Yonkers NEW YORK 10701
P: 19142072300.0
CEO: Roger J. Pomerantz
Employees: 23
Website: https://www.contrafect.com/
ContraFect plans to raise $15 million through the sale of common stock and warrants. Read more.
It's time to start off the workweek with a detailed breakdown of the biggest pre-market stock movers for Monday morning!
We're starting off Thursday with a breakdown of the biggest pre-market stock movers traders need to know about this morning!
Rite Aid stock is taking a beating on Monday as investors in RAD react to the company filing for Chapter 11 bankruptcy protection.
Nxu stock is falling on Monday after the company reported insider selling of its shares as well as addressing a delisting notice.
Sigma Additive Solutions stock is sliding lower on Monday as shares of SASI give up gains from an acquisition announcement on Friday!
Here you can normally see the latest stock twits on CFRX, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: